Characteristic | No. (%) |
---|---|
Gender | |
 Male | 96 (54.2) |
 Female | 81 (45.8) |
Age | |
  < 55 years | 38 (21.5) |
 55–65 years | 55 (31.1) |
 65.1–75 years | 57 (32.2) |
 75.1–90 | 27 (15.2) |
BMI | |
 Underweight (<18.5) | 12 (6.8) |
 Normal (18.5 < =BMI < 25) | 74 (41.8) |
 Overweight (25 < =BMI < 30) | 57 (32.2) |
 Obese (> = 30) | 34 (19.2) |
Smoking history | |
 Current/recenta | 52 (29.4) |
 Former | 81 (45.8) |
 Never | 44 (24.8) |
Race | |
 White or Caucasian | 148 (83.6) |
 Black or African American | 24 (13.6) |
 Asian | 2 (1.1) |
 Other | 3 (1.7) |
Stage | |
 Stage I | 13 (7.4) |
 Stage II | 12 (6.8) |
 Stage III | 28 (15.8) |
 Stage IV | 122 (68.9) |
 Unknown | 2 (1.1) |
# of metastasis sites | |
 0 | 85 (48.0) |
 1 | 64 (36.2) |
 2 | 18 (10.2) |
  ≥ 3 | 10 (5.6) |
Vital status | |
 Alive | 118 (66.7) |
 Dead | 59 (33.3) |
Tumor type | |
 Lung adenocarcinoma | 52 (29.4) |
 Non-small cell lung cancer-not otherwise specified | 24 (13.5) |
 Lung squamous carcinoma | 21 (11.9) |
 Head/Neck | 16 (9.0) |
 Colorectal | 12 (6.8) |
 Cancer of unknown primary (CUP) | 12 (6.8) |
 Other | 9 (5.1) |
 Pancreas | 7 (3.9) |
 Other GI | 6 (3.4) |
 Small cell lung cancer | 6 (3.4) |
 Breast | 3 (1.7) |
 Kidney | 3 (1.7) |
 Liver | 3 (1.7) |
 Prostate | 3 (1.7) |